Physiotherapist. PhD in Oncology at AC Camargo Cancer Center. Master in Health Technology from PUCPR. Specialist in Women’s Health – COFFITO/ABRAFISM. Specialist in Oncological Physiotherapy – COFFITO/ABFO. Specialist in Acupuncture – COFFITO. Specialization in Human Sexuality – CERTRO. Professor at the University of Vale do Itajaí (UNIVALI) Itajaí-SC since 2002. Office in Brusque-SC.

General surgeon. – specialist in oncological surgery, mastology and plastic and reconstructive surgery. – surgeon of the mastology department of the “ángel h.roffo” institute of oncology. – teaching coordinator of the fellowship program in mastology, oncological and reconstructive breast surgery of the department of mastology of the “ángel h. Roffo” institute of oncology. – full member of the argentine society of mastology and the argentine association of surgery.

Degree in Medicine from the Federal University of Alagoas (1999), medical residency (lato sensu specialization) in Internal Medicine (1999-2001) and Clinical Oncology, with emphasis on the diagnosis and treatment of onco-hematological diseases and solid tumors (2001-2004 ) by the National Cancer Institute/INCA – MS. Title of Specialist in Clinical Cancerology by AMB/SBC (2004). Assistant Physician and Preceptor of Medical Residency in Clinical Oncology at Hospital das Clínicas de São Paulo/USP (2004-2006). Master’s Degree in Oncology (2008) from the University of São Paulo (USP). Assistant Physician at the Clinical Oncology Service at the Hospital do Câncer de Pernambuco from July/2008 to March/2013. Coordinator of the Committee for Ethics in Research Involving Human Beings of the Pernambuco Society of Combat/Hospital de Câncer de Pernambuco from May/2009 to March/2013. Coordinator of the Clinical Research Center of the Hospital do Câncer de Pernambuco from May/2010 to March/2013. Preceptor of Medical Residency in Clinical Oncology at Hospital das Clínicas da UFPE since 2015. Member of the Brazilian Society of Clinical Oncology (SBOC), American Society of Clinical Oncology (ASCO), European Society of Medical Oncology (ESMO) and American Association for Cancer Research (AACR). Training in Medical Residency Preceptorship (2020) by Hospital Alemão Oswaldo Cruz/PROADI-SUS/MS. PhD in Applied Biology to Health (PhD) from the Federal University of Pernambuco (2018). Head of the Oncology and Hematology Unit at Hospital das Clinicas/EBSERH/UFPE(from July/2019 to July/2021). Graduate/Specialization in Clinical Research by UNISA-SP (2021) with Training Course in Clinical Research (2016) by Hospital Alemão Oswaldo Cruz/PROADI-SUS/MS. Graduate/Specialist in Breast Oncology at the Albert Eistein Teaching and Research Institute – Hospital Israelita Albert Einstein-SP (2021) Adjunct Professor (Superior Teaching) of Medicine (2022) at the Center for Medical Sciences/Faculty of Medicine of Recife – University Federal of Pernambuco (UFPE). Researcher at LIKA Institute (Kenzo Asami Immunopathology Laboratory) – UFPE since 2019). Head of the Care Management Division of the Health Care Management at Hospital das Clínicas-UFPE/EBSERH (since August/2021). Areas of interest: Study of Breast Neoplasms, Genitourinary Tumors, Biomarkers, Molecular Targeted Therapies, Clinical Trials, and Predictive Factors of Response to oncological therapies.

Dr. Hayden Carlton currently works as a Postdoctoral Research Fellow at the Johns Hopkins School of Medicine in the Department of Radiation Oncology and Molecular Radiation Sciences. His work in Dr. Robert Ivkov’s lab focuses on the usage of magnetic nanoparticles for cancer treatment, specifically with thermal therapies like magnetic nanoparticle hyperthermia. Dr. Carlton received his PhD in Mechanical Engineering from the University of Arkansas in 2021, where his research focused primarily on the study of heat transfer in micro and nanoscale systems.

Is an Associate Professor in the Department of Internal Medicine and Clinical Director of the Breast Cancer Program at Simmons Cancer Center at UT Southwestern Medical Center. She specializes in breast cancer research and treatment.

Dr. McArthur earned her medical degree at the University of Toronto and completed a residency in internal medicine at the University of Calgary. She received advanced training through a medical oncology fellowship at the University of British Columbia and an advanced clinical research fellowship in breast cancer at Memorial Sloan Kettering Cancer Center.

She also holds a master’s degree in public health from Harvard University.

Dr. McArthur joined the UT Southwestern faculty in 2021. Previously, she served as Medical Director of Breast Oncology at Cedars-Sinai Medical Center in Los Angeles.

At UT Southwestern, she serves as the Komen Distinguished Chair in Clinical Breast Cancer Research. Her research focuses on innovations in the diagnosis and treatment of breast cancer, and she has a special interest in developing immunotherapy strategies.

The author of more than 100 research articles and abstracts, she has been a reviewer for medical journals including Cancer, Journal of Clinical Oncology, Nature, and New England Journal of Medicine. She currently serves as an Associate Editor for Breast Cancer Research and on the editorial boards for Cancer and Breast Cancer Research and Treatment.

She also serves on the Alliance for Clinical Trials in Oncology’s Immuno-Oncology Committee Advisory Council, Oncology Education’s Scientific Steering Committee, and the National Cancer Institute’s Breast Immuno-Oncology Task Force of the Breast Cancer Steering Committee.

Dr. McArthur is a member of the American Association for Cancer Research, the American Society of Clinical Oncology, and the Southwest Oncology Group.

 Benigno Acea Nebril

Benigno Acea Nebril currently works at the Breast Unit, Complexo Hospitalario Universitario A Coruña (Spain). Graduated in medicine 1988 and specialized in General Surgery 1995. Philosophy Doctor degree 1998. Director of Advanced Course of Oncoplastic and Reconstructive Breast Surgery at Spain and Latin America since 2006. Founder of website www.breastsurgeonsweb.com and the application Oncoplastic. Benigno does research in Oncoplastic Surgery, Oncology and Surgery.

Mastólogo Ginecólogo, Centro de Patología mamaria del Hospital San Borja Arriarán desde el 2000. Fellow en Oncoplástica y Reconstrucción Mamaria (IEO, Milán, 2005-2006) Jefe de Departamento de cirugía reconstructiva mamaria de Hospital San Borja Arriarán Profesor de Medicina, Universidad de Chile. Director de Sociedad Chilena de Mastología Mastólogo Oncoplástico en Clínicas Red Salud Vitacura y MEDS.

Associate Professor at the University of Brasília and Ph.D. in Nanobiotechnology. Has expertise in Nanomedicine, the author of scientific articles in this field. I was also the Coordinator of the Post-Graduation Programm in Nanoscience and Nanobiotechnology at the University of Brasília. Now is a Guest Editor of Pharmaceutics and Frontiers in Medicine, been also listed as an inventor of 8 Patents.

MD, MHCM, FACS just completed a year as Chief Transformation Officer of the Cancer Institute and Director of Growth and Strategy for the Breast Program at Allegheny Health Network, Pittsburgh PA. She completed a fellowship in breast surgical oncology and general surgery residency at Cleveland Clinic and received her Master’s in Health Care Management from Harvard School of Public Health. She is Principal at TrueNorth Medical Consulting LLC, focusing on value-based transformation and Centers of Excellence guidance. Dr Dietz is the past president and Chairman of the Board of the American Society of Breast Surgeons and Vice Chair of the National Accreditation Program for Breast Centers (NAPBC). Dr Dietz co-leads Global Breast Hub and serves as an advisor to Breast Global, international organizations with a mission to lessen gaps in breast cancer care around the world. Dr Dietz led the multi-society Breast Cancer Pandemic Consortium to establish a prioritization recommendation, has taken part in guideline and consensus statement development, has served as faculty in many courses, and is a frequent international invited speaker. Her current clinical and research interests include oncoplastic surgery, value-based and patient-centric care and the surgical techniques that promote such care delivery.

Currently she is a professor in the Chemistry Department at the Faculty of Philosophy, Sciences and Letters of Ribeirão Preto (FFCLRP-USP) and one of the coordinators of the nanotoxicology group at the Institute for Advanced Studies (IEA-USP) São Carlos-SP. Graduated in Chemistry from State University of Maringá, she obtained her Master’s and Doctorate in Sciences – area of concentration in Analytical Chemistry – in the Chemistry Institute of São Carlos of the University of São Paulo (IQSC-USP). During her doctorate she performed a sandwich internship at Rühr Universität, Germany under the supervision of Prof. Dr. Wolfgang Schuhmann. She did her postdoctoral work at IFSC in the Nanomedicine and Nanotoxicology Group. She was a visit researcher at the Center for Bionano Interactions coordinated by Prof. Dr Kenneth A. Dawson, University College Dublin, Ireland. His research is focused on the application of analytical techniques in Nanomedicine and Nanotoxicology, working mainly in the development of theranostic nanoparticles, sensors and biosensors, and toxicology of nanomaterials. She published around 37 international articles that received more than 941 citations (h index = 17 and i10 index = 25), in addition to book chapters and patent filing. She has given more than 20 national and international lectures, and serves as a reviewer for numerous international scientific journals.

Dr. Julia Camps-Herrero is a breast radiologist and also the Corporate Chief of Breast Health in five Ribera Salud hospitals in Spain (University Hospitals of Torrejon, POVISA, Vinalopó, Denia, and Polusa). From 2006 to 2019 she was appointed Head of the Radiology Department at University Hospital de la Ribera in Alzira (Valencia). Since 1999 she is an active researcher in multimodality breast radiology, with a special interest in MRI, CEM and minimally invasive interventions. Dr Camps-Herrero is an active speaker in Latin America and Europe, where she has been invited to lecture in more than 400 presentations. She is the author of 30 papers, 7 book chapters and 75 scientific posters and oral presentations. Currently, she is the Vice-president of SEDIM (Spanish Breast Imaging Society) and a Past-President of the European Society of Breast Imaging (EUSOBI).

Degree in Biological Sciences from PUC-GO; Master’s Degree in Biology with emphasis in Cellular and Molecular Biology from UFG-GO Executive MBA in Business Administration – Health Management from FGV; 15 years of experience in Clinical Research in Oncology as a study coordinator, financial analyst and contract analyst.

Nurse graduated from Universidade Paulista, (2011) and specialist in Health Systems Auditing from PUC GO. She is currently a Nurse and Senior Coordinator of Clinical Research at the Study Center of the Gynecology and Breast Service of the Associação de Combate ao Câncer in Goiás – Hospital Araújo Jorge, acting in the coordination of research protocols, quality control of clinical studies phases Ib, II and III and multidisciplinary team management. Senior experience in coordinating studies in oncology focused on female tumors and with a focus on breast cancer.

Senior Scientist at CureVac SE (Tübingen, GER). She obtained her Ph.D. in Pharmaceutics and Drug Delivery Systems at Northeastern University in 2018 (Boston, USA), after graduating from Federal University of Goiás, Brazil, with a B.Sc. in Pharmacy (2010) and M.Sc. in Pharmaceutical Sciences (2012). Research experience spanning over 15 years, working mostly with the development of lipid and polymeric nanoparticles for the delivery of anti-cancer drugs and gene delivery systems